What is the equity of Biosynex this year?
Biosynex has equity of 124.48 M EUR this year.
Biosynex Equity 2024
Biosynex Equity
124.48 M EUR
Ticker
ALBIO.PA
ISIN
FR0011005933
WKN
A1H8G1
In 2024, Biosynex's equity was 124.48 M EUR, a -23.4% increase from the 162.5 M EUR equity in the previous year.
Biosynex Aktienanalyse
What does Biosynex do?
The company Biosynex SA was founded in 2005 in Strasbourg, France. The company is a manufacturer and distributor of diagnostic test kits used for the rapid and accurate diagnosis of various infectious diseases and other health conditions. Biosynex SA has established itself as a leading player in the global health market in recent years. The business model of Biosynex SA includes the design, manufacture, and distribution of various medical diagnostic tests that are capable of quickly and efficiently detecting pathogens and other health conditions. The company offers a wide range of medical test kits that can be used for the diagnosis of HIV/AIDS, hepatitis C, syphilis, rapid pregnancy tests, menopause, bleeding during pregnancy, vitamin D deficiency, and many other health conditions. The main focus of Biosynex SA is on developing test kits that are easy to use and provide accurate and reliable results. With its technological know-how and collaboration with leading experts in the field of medical diagnostics, Biosynex SA has taken a leading position in the development and marketing of medical diagnostic test kits. By collaborating with doctors, hospitals, and clinics globally, Biosynex SA has successfully expanded its business. Biosynex SA has various business areas specifically focused on the marketing and distribution of medical diagnostic tests. The most well-known areas include gynecology, infectious diseases, and pediatrics. Biosynex SA also has a strong presence in the global market, including Asia, Europe, Africa, and America. One of the most well-known products of Biosynex SA is the HIV self-test called Autotest VIH®, which is available in many European countries and North America. The test kit is CE marked and approved by leading health authorities such as the WHO and the EU. The product is an important tool in reducing the spread of HIV infections and allowing people to make a confidential diagnosis of HIV/AIDS in a private setting. In the field of gynecology, Biosynex SA offers various products such as the Unistick® pregnancy test, Unistick® ovulation test, and Unistick® menopause test kit. These products enable women to easily and efficiently diagnose pregnancy, ovulation, and menopause. The test kits are easy to use, can be used at home, and provide results within minutes. In summary, Biosynex SA has earned its leading position in the global market due to its focus on innovative technology and high-quality product range. The company has made a significant contribution to improving healthcare worldwide with its expertise and commitment to diagnosing health conditions. Biosynex SA will continue to expand its business in the future to support even more people worldwide and further improve the quality of healthcare. Biosynex ist eines der beliebtesten Unternehmen auf Eulerpool.com.Equity Details
Analyzing Biosynex's Equity
Biosynex's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Biosynex's equity is essential for assessing its financial health, stability, and value to shareholders.
Year-to-Year Comparison
Evaluating Biosynex's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.
Impact on Investments
Biosynex's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.
Interpreting Equity Fluctuations
Fluctuations in Biosynex’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.
Frequently Asked Questions about Biosynex stock
What was the equity of Biosynex compared to the previous year?
The equity of Biosynex has increased/decreased by -23.4% decreased compared to the previous year.
What impact does a high equity have on investors of Biosynex?
A high equity is advantageous for investors of Biosynex as it is an indicator of the company's financial stability and its ability to manage risks and challenges.
What impact does low equity have on investors of Biosynex?
A low equity can be a risk for investors of Biosynex, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.
How does an increase in equity of Biosynex affect the company?
An increase in equity of Biosynex can strengthen the company's financial position and improve its ability to make investments in the future.
How does a reduction in the equity of Biosynex affect the company?
A reduction in equity of Biosynex can affect the financial situation of the company and lead to a higher dependence on debt capital.
What are some factors that influence the equity of Biosynex?
Some factors that can affect the equity of Biosynex include profits, dividend payments, capital increases, and acquisitions.
Why is the equity of Biosynex so important for investors?
The equity of Biosynex is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.
What strategic measures can Biosynex take to change the equity?
To change equity, Biosynex can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.
How much dividend does Biosynex pay?
Over the past 12 months, Biosynex paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Biosynex is expected to pay a dividend of 0 EUR.
What is the dividend yield of Biosynex?
The current dividend yield of Biosynex is .
When does Biosynex pay dividends?
Biosynex pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Biosynex?
Biosynex paid dividends every year for the past 2 years.
What is the dividend of Biosynex?
For the upcoming 12 months, dividends amounting to 0 EUR are expected. This corresponds to a dividend yield of 0 %.
In which sector is Biosynex located?
Biosynex is assigned to the 'Health' sector.
Wann musste ich die Aktien von Biosynex kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Biosynex from 5/18/2022 amounting to 2 EUR, you needed to have the stock in your portfolio before the ex-date on 5/16/2022.
When did Biosynex pay the last dividend?
The last dividend was paid out on 5/18/2022.
What was the dividend of Biosynex in the year 2023?
In the year 2023, Biosynex distributed 2 EUR as dividends.
In which currency does Biosynex pay out the dividend?
The dividends of Biosynex are distributed in EUR.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Biosynex
Our stock analysis for Biosynex Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Biosynex Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
